Citation Impact
Citing Papers
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Electrocardiography of myocarditis revisited: Clinical and prognostic significance of electrocardiographic changes
1992
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy
2001 StandoutNobel
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
2009 Standout
Evaluation of Diastolic Filling of Left Ventricle in Health and Disease: Doppler Echocardiography Is the Clinician’s Rosetta Stone
1997
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
1996 Standout
Valvular Heart Disease Associated with Fenfluramine–Phentermine
1997 Standout
Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
2015
The Failing Heart — An Engine Out of Fuel
2007 Standout
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008
A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutation
1990 Standout
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
2010 Standout
The metabolic syndrome
2010 Standout
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy
1999
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Paracrine and autocrine effects of nitric oxide on myocardial function
2000
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
HEART FAILURE WITH NORMAL SYSTOLIC FUNCTION
2000
The metabolic syndrome
2005 Standout
End-point immobilization of heparin on plasma-treated surface of electrospun polycarbonate-urethane vascular graft
2017
US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988-2008
2010 Standout
Preparation and characterization of hydrophobic polymeric films that are thromboresistant via nitric oxide release
2000
Cardiac Resynchronization in Chronic Heart Failure
2002 Standout
Role of mechanical and hormonal factors in cardiac remodeling and the biologic limits of myocardial adaptation
1993
Impact of Renin-Angiotensin System Blockade Therapy on Outcome in Aortic Stenosis
2011
Bladder cancer
2016 Standout
Prognostic Importance of Elevated Jugular Venous Pressure and a Third Heart Sound in Patients with Heart Failure
2001 Standout
Diastolic Heart Failure in the Elderly
2007
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
Hypoxia of the Renal Medulla — Its Implications for Disease
1995 Standout
Exercise capacity in hypertrophic cardiomyopathy depends on left ventricular diastolic function
1999
Burden of valvular heart diseases: a population-based study
2006 Standout
Cardiac Plasticity
2008
Diastolic Heart Failure in the Elderly
2007
Alzheimer's Disease
2010 Standout
Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise
1999
Hypertrophic Cardiomyopathy
2002 Standout
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: Results and clinical implications
1994
What do we need for a superhydrophobic surface? A review on the recent progress in the preparation of superhydrophobic surfaces
2007 Standout
Burden of Systolic and Diastolic Ventricular Dysfunction in the Community
2003 Standout
Antifouling Coatings: Recent Developments in the Design of Surfaces That Prevent Fouling by Proteins, Bacteria, and Marine Organisms
2010 Standout
Myocarditis
2009 Standout
Superhydrophobic modification fails to improve the performance of small diameter expanded polytetrafluoroethylene vascular grafts
2002
Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications
2019 Standout
QUANTITATIVE OPTICAL SPECTROSCOPY FOR TISSUE DIAGNOSIS
1996
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Diastolic filling dynamics in patients with aortic stenosis.
1986
Diabetes and Endothelial Dysfunction: A Clinical Perspective
2001
Carcinoid Heart Disease
1995
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
2010 Standout
Live tissue intrinsic emission microscopy using multiphoton-excited native fluorescence and second harmonic generation
2003 Standout
Recent Advances in the Molecular Genetics of Hypertrophic Cardiomyopathy
1995
Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
1984 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Contemporary Definitions and Classification of the Cardiomyopathies
2006 Standout
Mechanisms and Models in Heart Failure
2005
Factors influencing the one-year mortality of dilated cardiomyopathy
1984
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Prognosis of patients with hypertrophic obstructive cardiomyopathy after transaortic myectomy. Late results up to twenty-five years.
1993
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Two-Photon Absorbing Nanocrystal Sensors for Ratiometric Detection of Oxygen
2009 StandoutNobel
Clinical Utility of Doppler Echocardiography and Tissue Doppler Imaging in the Estimation of Left Ventricular Filling Pressures
2000 Standout
PROLONGATION OF SURVIVAL IN CONGESTIVE CARDIOMYOPATHY BY BETA-RECEPTOR BLOCKADE
1979
Defense Strategies Against Hypoxia and Hypothermia
1986 Science
Classification and natural history of primary myocardial disease
1984
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Catecholamines, Cardiac β-Adrenergic Receptors, and Heart Failure
2000 StandoutNobel
Relationship between myosin isoenzyme composition, hemodynamics, and myocardial structure in various forms of human cardiac hypertrophy.
1985
Organization of β-adrenoceptor signaling compartments by sympathetic innervation of cardiac myocytes
2007 StandoutNobel
Nitric Oxide Is Responsible for Flow-Dependent Dilatation of Human Peripheral Conduit Arteries In Vivo
1995 Standout
Beneficial effects of long-term beta-blockade in congestive cardiomyopathy.
1980
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
2005 Standout
Works of Hess Om being referenced
Intracardiac Ace Inhibition Improves Diastolic Distensibility in Patients With Left-ventricular Hypertrophy Due To Aortic-stenosis
1992
Bronchial neuroendocrine (carcinoid) tumor causing unilateral left-sided carcinoid heart disease
1991
Fluorescence spectroscopy for identification of atherosclerotic tissue
1992
Sexual activity in hypertensive men
2003
Left ventricular systolic function in aortic stenosis
1988
Flow-dependent vasodilation in the coronary circulation: alterations in diseased states.
1998
There are no reliable preoperative markers of postoperative persistent left ventricular dysfunction.
1986
Left ventricular function and myocardial structure in aortic valve disease before and after surgery.
1984
Abnormal coronary vasomotion during exercise in patients with normal coronary arteries and reduced coronary flow reserve.
1989
Improvement of patency rate in heparin-coated small synthetic vascular grafts.
1998
[Clinical course of congestive cardiomyopathy].
1976
[Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propranolol and verapamil].
1983
Regional left ventricular mechanics in hypertrophic cardiomyopathy.
1993
[Latent cardiomyopathy - an early form of congestive cardiomyopathy].
1981
Physiologic or pathologic hypertrophy
1983
Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis.
1994
[Computer-assisted evaluation of echo pressure curves of the left ventricle in patients with myocardial hypertrophy; importance of myocardial morphology].
1979
[Clinical value of endomyocardial biopsy].
1979